| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |